2015-11-10T08:40:41-06:00 2014-12-31 231406493 MORISON COGEN LLP 150 MONUMENT RD - STE 500 BALA CYNWYD PA 19004 990 2014-01-01 232818395 NATIONAL COMPREHENSIVE CANCER NETWORK NATI 2156900300 275 COMMERCE DRIVE NO 300 FORT WASHINGTON PA 19034 LISA KIMBRO CHIEF FINANCIAL OFFICER 2156900300 2015-11-04 1 JOSEPH M KISTNER CPA P00157086 2674403000 2014 2016-03-07 17:11:31Z ROBERT W CARLSON MD 275 COMMERCE DRIVE NO 300 FORT WASHINGTON PA 19034 27949858 0 X WWW.NCCN.ORG X 1993 DE OUR MISSION, AS AN ALLIANCE OF LEADING CANCER CENTERS DEVOTED TO PATIENT CARE, RESEARCH, AND EDUCATION IS TO IMPROVE THE QUALITY, EFFECTIVENESS, AND EFFICIENCY OF CANCER CARE SO THAT PATIENTS CAN LIVE BETTER LIVES. 25 25 96 1150 210971 49999 14251457 16954382 7974208 10237396 65795 32666 675508 725414 22966968 27949858 2936757 2713763 0 0 10683431 11633809 0 0 554440 8761727 8674301 22381915 23021873 585053 4927985 25948086 35074025 11366482 15566153 14581604 19507872 X OUR MISSION, AS AN ALLIANCE OF LEADING CANCER CENTERS DEVOTED TO PATIENT CARE, RESEARCH, AND EDUCATION IS TO IMPROVE THE QUALITY, EFFECTIVENESS, AND EFFICIENCY OF CANCER CARE SO THAT PATIENTS CAN LIVE BETTER LIVES. 0 0 11048927 8943890 WITH EXPERTS FROM MAJOR ACADEMIC CANCER CENTERS, DEVELOP AND UPDATE CLINICAL PRACTICE GUIDELINES FOR TREATMENT OF CANCER; INCLUDES FREE DISTRIBUTION OF CONTENT, AND EDUCATIONAL CONFERENCES AND SYMPOSIA TO COMMUNICATE CONTENT. 4283021 2713763 DEVELOPMENT OF A CLINICAL RESEARCH NETWORK OF PHYSICIANS AT MEMBER ACADEMIC CANCER CENTERS TO FACILITATE THE CONDUCT OF STUDIES TO ADVANCE THE STATE-OF-THE-ART IN CANCER CARE. 2304430 1282880 DISSEMINATION OF PATIENT INFORMATION BASED ON GUIDELINES; DEVELOPMENT AND DISSEMINATION OF MEASURES TO ACCESS THE QUALITY OF CARE. 1719767 736040 DEVELOPMENT OF OTHER PUBLIC AND PROFESSIONAL INFORMATION PROGRAMS TO FACILITATE ACCESS TO CANCER SPECIALTY SERVICES. 1719767 736040 19356145 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 231 0 1 96 1 1 1 0 0 0 0 0 0 0 0 0 X 25 25 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT FL GA HI IL KS KY LA ME MD MA MI MS MN MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X LISA KIMBRO 2156900300 275 COMMERCE DRIVE SUITE 300 FORT WASHINGTON PA 19034 JOANNE MORTIMER MD FACP DIRECTOR 2.00 X 0 0 0 MARA G BLOOM JD MS DIRECTOR, SECRETARY 2.00 X 0 0 0 THOMAS A D'AMICO MD DIRECTOR 2.00 X 0 0 0 PAUL F ENGSTROM MD FACP DIRECTOR 2.00 X 0 0 0 PETER F COCCIA MD DIRECTOR 2.00 X 0 0 0 F MARC STEWART MD DIRECTOR 2.00 X 0 0 0 RAY LYNCH CPA MBA DIRECTOR, TREASURER 2.00 X 0 0 0 JAN C BUCKNER MD DIRECTOR 2.00 X 0 0 0 DAVID G PFISTER MD DIRECTOR 2.00 X 0 0 0 G DOUGLAS LETSON MD DIRECTOR 2.00 X 0 0 0 AL B BENSON III MD FACP FASCO DIRECTOR 2.00 X 0 0 0 DONALD L TRUMP MD FACP DIRECTOR 2.00 X 0 0 0 TIMOTHY J EBERLEIN MD DIRECTOR, VICE-CHAIR 2.00 X 0 0 0 LARRY E KUN MD DIRECTOR 2.00 X 0 0 0 DOUGLAS W BLAYNEY MD DIRECTOR 2.00 X 0 0 0 WILLIAM E CARSON III MD DIRECTOR 2.00 X 0 0 0 DAVID S ETTINGER MD FACP FCCP DIRECTOR 2.00 X 0 0 0 RANDAL S WEBER MD DIRECTOR 2.00 X 0 0 0 BARBARA PARKER MD DIRECTOR 2.00 X 0 0 0 PETER R CARROLL MD MPH DIRECTOR 2.00 X 0 0 0 LISLE M NABELL MD DIRECTOR 2.00 X 0 0 0 W THOMAS PURCELL MD MBA DIRECTOR 2.00 X 0 0 0 SAMUEL M SILVER MD PHD MACP DIRECTOR, CHAIR 2.00 X 0 0 0 MICHAEL N NEUSS MD DIRECTOR 2.00 X 0 0 0 THOMAS J LYNCH JR MD DIRECTOR 2.00 X 0 0 0 ROBERT W CARLSON MD CHIEF EXECUTIVE OFFICER 40.00 X 552928 0 59358 GARY WEYHMULLER CHIEF OPERATING OFFICER 40.00 X 296462 0 22239 LISA G KIMBRO CHIEF FINANCIAL OFFICER 40.00 X 291372 0 49367 JOAN S MCCLURE SENIOR VP, CLINICAL INFORM 40.00 X 294235 0 52368 C LYN FITZGERALD VICE PRESIDENT, US & GLOBA 40.00 X 227738 0 60058 KRISTINA M GREGORY VICE PRESIDENT, CLINICAL I 40.00 X 212918 0 31671 DIANE E PAUL VICE PRESIDENT, ONCOLOGY R 40.00 X 207495 0 45042 LINDA LEACH DIRECTOR, ADMINISTRATION AND HUMAN RESOURCES 40.00 X 187657 0 23331 LAUREN GALLAGHER DIRECTOR DRUGS & BIOLOGICS 40.00 X 174861 0 45455 PATRICIA J GOLDSMITH FORMER - CHIEF OPERATING OFFICER 40.00 X 155357 0 12092 2601023 0 400981 26 1 1 0 THE WESTIN DIPLOMAT RESORT & SPA 3555 S OCEAN DRIVE HOLLYWOOD FL 33019 CONFERENCE PRODUCTION 1225755 IBM CORPORATION 275 VIGER EAST MONTREAL, QUEBEC CA H2X 3R7 SOFTWARE CONSULTING 852868 CLINICAL CARE OPTIONS LLC 12001 SUNRISE VALLEY DRIVE SUITE 3 RESTON VA 20191 PROFESSIONAL SERVICES 518000 PHOENIX LITHOGRAPHING 11631 CAROLINE ROAD PHILADELPHIA PA 19154 PRINTING 394468 SYANDUS INC 760 CONSTITUTION DRIVE SUITE 106 EXTON PA 19341 PROFESSIONAL SERVICES 327500 18 2985649 13968733 16954382 PERMISSION FEES 900099 2484075 2484075 LICENSE FEES 900099 1998096 1998096 GUIDELINE DISTRIBUTION 900099 1686430 1686430 SUBSCRIPTIONS 900099 1130230 1130230 2938565 2938565 10237396 32666 32666 514443 514443 ADVERTISING 541800 210971 210971 210971 27949858 10751839 210971 32666 2713763 2713763 1434999 1130820 271588 32591 7473571 6498636 604010 370925 496004 427098 46033 22873 1679802 1446440 155900 77462 549433 473104 50992 25337 343897 173569 170328 48300 12500 35800 429918 405005 24913 52571 32375 20196 112808 57525 54713 570 1386886 1214438 172443 5 926430 926430 868359 696499 154859 17001 2142838 2142838 176706 78260 98446 103980 4 103976 HONORARIA 576043 576043 PRINTING AND PUBLICATIO 521532 522528 -996 CONTINGENCY/BAD DEBT 119702 118182 1520 EQUIPMENT RENTAL & MAIN 35445 35445 828886 636518 184692 7676 23021873 19356145 3111288 554440 4538577 10123792 15645978 15676926 2160685 4798649 2792655 3792715 27777 0 307431 308138 1934134 1560329 474983 373805 25948086 35074025 2332675 1983788 9033807 13582365 11366482 15566153 X 9307820 13762542 5273784 5745330 14581604 19507872 25948086 35074025 4927985 -1717 0 X X 0 1 X 1 0 X 22254488 16909721 14901085 14251457 16954382 85271133 22254488 16909721 14901085 14251457 16954382 85271133 21408632 63862501 151856 460409 614667 567540 547109 2341581 62096 80716 142812 2761376 8829913 7432102 7974208 10237397 37234996 124990522 0.51090 0.48390 X SCHEDULE A - PART II SECTION B LINE 10 OTHER INCOME INCLUDES THE FOLLOWING ITEMS: GUIDELINE DISTRIBUTION $1,686,430 PERMISSION FEES 2,484,075 SUBSCRIPTION REVENUE FROM THE NCCN COMPENDIA, CHEMOTHERAPY ORDER TEMPLATES AND FLASH UDPATES 1,130,230 LICENSE FEE REVENUE FOR LICENSING OF NCCN'S PRODUCTS 1,998,095 REGISTRATION FEES FOR NCCN EDUCATIONAL PROGRAMS 483,867 TRENDS SURVEY FEES FOR NCCN TRENDS REPORTS 238,000 TUITION FEES FOR NCCN ACADEMY 468,690 ACCESS FEES FOR NCCN CONTENT 62,500 EXHIBIT FEES FOR EXHIBITING AT NCCN EDUCATIONAL PROGRAMS 646,750 CONSULTING REVENUE 771,408 FELLOWSHIP GRANT 267,352 TOTAL $10,237,397 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 208080 33294 174786 1726054 1527035 199019 373805 X 27948141 -1717 -1717 27949858 0 27949858 23021873 0 23021873 0 23021873 PART X, LINE 2: NCCN FOLLOWS FASB ISSUED ACCOUNTING STANDARDS UPDATE NO. 2009-06, INCOME TAXES (TOPIC 740): IMPLEMENTATION GUIDANCE ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES AND DISCLOSURE AMENDMENTS FOR NONPUBLIC ENTITIES TAXES. FASB ASC 740 PRESCRIBES GUIDANCE FOR THE FINANCIAL STATEMENT RECOGNITION, MEASUREMENT AND DISCLOSURE OF UNCERTAIN TAX POSITIONS. TAX POSITIONS MUST MEET A MORE-LIKELY-THAN-NOT RECOGNITION THRESHOLD. THERE WERE NO TAX POSITIONS FOR WHICH IT IS REASONABLY POSSIBLE THAT THE TOTAL AMOUNTS OF UNRECOGNIZED TAX BENEFITS WILL SIGNIFICANTLY INCREASE OR DECREASE WITHIN THE NEXT YEAR. TAX YEARS FROM 2011 THROUGH 2014 REMAIN SUBJECT TO EXAMINATION BY MAJOR TAX JURISDICTIONS. 1 BAPTIST CANCER CENTER 80 HUMPHREYS CENTER DRIVE SUITE 340 340 MEMPHIS TN 38120 621113167 501(C)(3) 98184 RESEARCH BARBARA ANN KARMANOS CANCER CENTER 4100 JOHN R MAIL CODE PR05RA DETROIT MI 48201 381613280 501(C)(3) 7500 RESEARCH CITY OF HOPE COMPREHENSIVE CANCER CENTER 1500 DUARTE ROAD DUARTE CA 91010 951683875 501(C)(3) 44429 RESEARCH DANA FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE BP320 BOSTON MA 02215 043320640 501(C)(3) 209797 RESEARCH FOX CHASE CANCER CENTER 640 COTTMAN AVENUE CHELTENHAM PA 19012 232003072 501(C)(3) 69540 RESEARCH H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 501(C)(3) 51654 RESEARCH HEALTH RESEARCH ASSOCIATION 1640 MARENGO STREET 7TH FLOOR LOS ANGELES CA 90033 951683862 501(C)(3) 7500 RESEARCH HEALTH RESEARCH INC ROSWELL PARK CANCER CENTER - ELM CARLTON STREETS BUFFALO NY 14263 141402155 501(C)(3) 322229 RESEARCH JOHNS HOPKINS UNIVERSITY 733 N BORADWAY SUITE 117 BALTIMORE MD 21205 520595110 501(C)(3) 198189 RESEARCH MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 10065 131624182 501(C)(3) 261907 RESEARCH NORTWESTERN UNIVERSITY HEALTH SYSTEM 750 N LAKE SHORE DRIVE 7TH FLOOR CHICAGO IL 60611 362167817 501(C)(3) 46996 RESEARCH THE OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER 1960 KENNY ROAD COLUMBUS OH 43210 316401599 501(C)(3) 465420 RESEARCH REGENTS OF THE UNIVERSITY OF CALIFORNIA 1855 FOLSOM STREET ROOM 425 SAN FRANCISCO CA 94143 946036493 501(C)(3) 204910 RESEARCH STANFORD UNIVERSITY PO BOX 44253 SAN FRANCISCO CA 941444253 941156365 501(C)(3) 37255 RESEARCH THE UNIVERSITY OF TEXAS 1515 HOLCOMBE AVENUE UNIT 176 HOUSTON TX 77030 746001118 501(C)(3) 298638 RESEARCH UNIVERSITY OF ALABAMA AT BIRMINGHAM COMPREHENSIVE CANCER CENTER 1824 6TH AVENUE SOUTH BIRMINGHAM AL 352943300 636005396 501(C)(3) 8750 RESEARCH UNIVERSITY OF MICHIGAN 3003 S STATE STREET ROOM 2044 ANN ARBOR MI 48104 386006309 501(C)(3) 132740 RESEARCH UNIVERSITY OF UTAH 75 SOUTH 2000 EAST CIRCLE OF HOPE SALT LAKE CITY UT 841128930 876000525 501(C)(3) 45000 RESEARCH UNIVERSITY OF WASHINGTON 825 EASTLAKE AVENUE SEATTLE WA 98109 916001537 115 5000 RESEARCH VANDERBILT UNIVERSITY MEDICAL CENTER DEPARTMENT OF FINANCE AT40303 ATLANTA GA 311920303 620476822 501(C)(3) 71669 RESEARCH WASHINGTON UNIVERSITY 700 ROSEDALE AVENUE ST LOUIS MO 63112 430653611 501(C)(3) 114100 RESEARCH YALE UNIVERSITY SCHOOL OF MEDICINE PO BOX 208087 HEW HAVEN CT 065208087 060646973 501(C)(3) 12356 RESEARCH 21 PART I, LINE 2: NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) ENTERS INTO RESEARCH GRANT AGREEMENTS WITH INSTITUTIONS TO CONDUCT RESEARCH FOR INDIVIDUAL STUDY PROJECTS APPROVED BY NCCN'S SCIENTIFIC REVIEW COMMITTEES. THE SCOPE AND NATURE OF STUDIES TO BE PERFORMED BY GRANT RECIPIENTS ARE IN ACCORDANCE WITH THE APPROVED PROTOCOLS DEVELOPED BY THE PRINCIPAL INVESTIGATORS AND CONSISTENT WITH THE PROPOSALS SUBMITTED TO AND APPROVED BY THE NCCN SCIENTIFIC REVIEW COMMITTEES. PRINCIPAL INVESTIGATORS MUST SIGN A CERTIFICATION FORM WITH AN ATTESTATION THAT THEY WILL ABIDE BY THE TERMS OF THE NCCN RESEARCH AGREEMENT AT ISSUE AND THAT THEY HAVE NOT BEEN DISBARRED UNDER ANY RELEVANT STATUTES. IF AN INSTITUTION DOES NOT COMMENCE A STUDY WITHIN NINE MONTHS OF APPROVAL, NCCN TERMINATES THE STUDY IF A CORRECTIVE ACTION PLAN IS NOT SUBMITTED BY THE INVESTIGATOR AND APPROVED BY NCCN. FUNDING THAT HAD BEEN SUPPLIED BY NCCN TO AN INSTITUTION FOR A STUDY THAT DOES NOT COMMENCE WITHIN THE APPLICABLE SPECIFIED TIME PERIOD MUST BE RETURNED IMMEDIATELY TO NCCN BY THE INSTITUTION. DURING THE TERM OF THE GRANT, INSTITUTIONS REPORT TO NCCN ON A QUARTERLY BASIS THE STATUS AND PROGRESS OF THE FUNDED STUDIES. REPORTS INCLUDE AN ASSESSMENT OF TOTAL ENROLLMENT, ELIGIBILITY, AND ACCRUAL OF PATIENTS. IN CONSIDERATION FOR PERFORMANCE OF THE STUDY, NCCN DISTRIBUTES GRANT MONIES TO INSTITUTIONS WHEN CERTAIN BENCHMARKS FOR PATIENT ACCRUAL ARE MET AND THE FINAL PAYMENT IS DISBURSED UPON RECEIPT OF FINAL REPORTS AND / OR MANUSCRIPTS. INSTITUTIONS ARE REQUIRED TO RECONCILE STUDY EXPENSES AT TERMINATION OR COMPLETION AND RETURN UNUSED FUNDS TO NCCN WHICH ARE IN TURN RETURNED TO THE GRANTOR. X X 1 0 0 0 0 0 0 0 0 ROBERT W CARLSON MD CHIEF EXECUTIVE OFFICER 503928 0 49000 0 0 0 26000 0 33358 0 612286 0 0 0 GARY WEYHMULLER CHIEF OPERATING OFFICER 296462 0 0 0 0 0 0 0 22239 0 318701 0 0 0 LISA G KIMBRO CHIEF FINANCIAL OFFICER 264890 0 26482 0 0 0 26000 0 23367 0 340739 0 0 0 JOAN S MCCLURE SENIOR VP, CLINICAL INFORM 267427 0 26808 0 0 0 26000 0 26368 0 346603 0 0 0 C LYN FITZGERALD VICE PRESIDENT, US & GLOBA 206938 0 20800 0 0 0 21268 0 38790 0 287796 0 0 0 KRISTINA M GREGORY VICE PRESIDENT, CLINICAL I 193597 0 19321 0 0 0 19515 0 12156 0 244589 0 0 0 DIANE E PAUL VICE PRESIDENT, ONCOLOGY R 188560 0 18935 0 0 0 19220 0 25822 0 252537 0 0 0 LINDA LEACH DIRECTOR, ADMINISTRATION AND HUMAN R 170712 0 16945 0 0 0 11262 0 12069 0 210988 0 0 0 LAUREN GALLAGHER DIRECTOR DRUGS & BIOLOGICS 174861 0 0 0 0 0 11673 0 33782 0 220316 0 0 0 PATRICIA J GOLDSMITH FORMER - CHIEF OPERATING OFFICER 155357 0 0 0 0 0 0 0 12092 0 167449 0 0 0 PART I, LINE 4A PATRICIA J. GOLDSMITH RECEIVED SEVERANCE OF $167,449 FORM 990, PART I, LINE 6, VOLUNTEERS: NCCN HAD 1,150 VOLUNTEERS COMMIT APPROXIMATELY 23,600 VOLUNTEER HOURS AS PANEL MEMBERS UPDATING EACH OF THE NCCN GUIDELINES FOR CANCER TREATMENT. FORM 990, PART VI, SECTION B, LINE 11 NCCN PROVIDES A DRAFT COPY OF THE FORM 990 TO THE FINANCE COMMITTEE OF THE BOARD OF DIRECTORS FOR ITS REVIEW AND APPROVAL PRIOR TO FILING THE RETURN. FORM 990, PART VI, SECTION B, LINE 12C NCCN REQUIRES OFFICERS, DIRECTORS, AND KEY EMPLOYEES TO ANNUALLY COMPLETE A CONFLICT OF INTEREST QUESTIONNAIRE. THIS QUESTIONNAIRE SHALL BE UPDATED AS NECESSARY TO REFLECT CHANGES DURING THE COURSE OF THE YEAR. COMPLETED QUESTIONNAIRES SHALL BE AVAILABLE FOR INSPECTION BY ANY BOARD MEMBER AND MAY BE REVIEWED BY NCCN'S LEGAL COUNSEL. SENIOR NCCN STAFF REVIEW THE CONFLICT OF INTEREST FORMS ANNUALLY, PROVIDE A REPORT TO THE EXECUTIVE COMMITTEE AND TAKE CORRECTIVE ACTION IF NEEDED. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION OF NCCN'S CEO IS REVIEWED PERIODICALLY BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CHAIRMAN OF NCCN'S BOARD OF DIRECTORS TO CONDUCT A SALARY COMPARABILITY STUDY AND SURVEY. THE INFORMATION FROM THE SURVEY CONDUCTED BY THE INDEPENDENT ORGANIZATION IS FORWARDED TO NCCN'S EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS FOR THEIR REVIEW. EACH YEAR, THE EXECUTIVE COMMITTEE OF NCCN'S BOARD OF DIRECTORS RECEIVES INFORMATION REGARDING THE CEO'S PAST SALARY HISTORY AS WELL AS THE CEO'S ACCOMPLISHMENTS. NCCN'S EXECUTIVE COMMITTEE SCHEDULES A CONFERENCE CALL TO REVIEW THIS INFORMATION AND TO DISCUSS RECOMMENDATIONS FOR THE CEO'S SALARY AND BONUS FOR THE UPCOMING YEAR. FORM 990, PART VI, SECTION B, LINE 15B: THE COMPENSATION OF NCCN'S CHIEF OPERATING OFFICER (COO), CHIEF FINANCIAL OFFICER (CFO), AND SENIOR VICE PRESIDENT OF CLINICAL INFORMATION AND PUBLICATIONS IS REVIEWED PERIODICALLY BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CEO OF NCCN. THE ORGANIZATION CONDUCTS A SALARY COMPARABILITY STUDY AND SURVEY FOR COMPARABLE POSITIONS IN SIMILAR ORGANIZATIONS. THE CEO REVIEWS THE SALARY STUDY AND SURVEY TO DETERMINE THE COMPENSATION FOR THE ABOVE KEY EMPLOYEES OF NCCN. FORM 990, PART VI, SECTION C, LINE 19 NCCN MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XII, LINE 2C: THE FINANCE COMMITTEE ASSUMES RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT AND SELECTION OF AN INDEPENDENT ACCOUNTANT. NCCN FOUNDATION 275 COMMERCE DRIVE STE 300 FORT WASHINGTON PA 19034 271536314 FOUNDATION DE 501(C)(3) LINE 7 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 NCCN FOUNDATION L 726477 FMV NCCN FOUNDATION O 522137 FMV PART V LINE 2C SALARIES AND BENEFITS $432,273 PROFESSIONAL FEES 36,042 TRAVEL AND MEETINGS 36,766 OFFICE EXPENSE 2,464 SUPPLIES AND PRINTING 2,892 OTHER EXPENSES 8,675 MARKETING & PUBLIC RELATIONS 1,488 TELEPHONE 1,537 TOTAL $522,137